G. Lambert

发表

Adherence to Zidovudine for the Prevention of Perinatal Transmission in HIV-Infected Pregnant Women: The Impact of Social Network Factors, Side Effects, and Perceived Treatment Efficacy

D. Thea, J. Weedon, E. Schoenbaum, 2005, Women & health.

Measles antibody in vaccinated human immunodeficiency virus type 1-infected children.

W. Bellini, L. Markowitz, S. Arpadi, 1996, Pediatrics.

Incubation period of HIV‐1 in perinatally infected children

R. Steketee, D. Thea, J. Weedon, 1998, AIDS.

Tuberculosis in human immunodeficiency virus-infected and human immunodeficiency virus-exposed children in New York City

K. Kaye, K. Bornschlegel, P. Thomas, 2000, The Pediatric infectious disease journal.

Disease progression and early viral dynamics in human immunodeficiency virus-infected children exposed to zidovudine during prenatal and perinatal periods.

L. Kuhn, J. Weedon, E. Abrams, 2000, The Journal of infectious diseases.

Association of human immunodeficiency virus (HIV) load early in life with disease progression among HIV-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

M. Kalish, R. Steketee, D. Thea, 1998, The Journal of infectious diseases.

Early detection of perinatal human immunodeficiency virus (HIV) type 1 infection using HIV RNA amplification and detection. New York City Perinatal HIV Transmission Collaborative Study.

M. Kalish, R. Steketee, D. Thea, 1997, The Journal of infectious diseases.

Efficacy of antenatal zidovudine in reducing perinatal transmission of human immunodeficiency virus type 1. The New York City Perinatal HIV Transmission Collaborative Study Group.

M. Hernán, D. Thea, P. Thomas, 1995, The Journal of infectious diseases.

Neonatal predictors of infection status and early death among 332 infants at risk of HIV-1 infection monitored prospectively from birth. New York City Perinatal HIV Transmission Collaborative Study Group.

D. Thea, N. Shaffer, P. Thomas, 1995, Pediatrics.

Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies

M. Schluchter, J. Goedert, P. Boisse, 2001, AIDS.

Heterosexual behavior during pregnancy and perinatal transmission of HIV-1. New York City Perinatal HIV Transmission Collaborative Study Group.

M. Chiasson, D. Thea, P. Thomas, 1996, AIDS.

Zidovudine use to reduce perinatal HIV type 1 transmission in an urban medical center.

A. Wiznia, G. Lambert, M. Crane, 1996, JAMA.

Maternal adherence to the zidovudine regimen for HIV-exposed infants to prevent HIV infection: a preliminary study.

D. Thea, M. Webber, J. Weedon, 2002, Pediatrics.

Distinct risk factors for intrauterine and intrapartum human immunodeficiency virus transmission and consequences for disease progression in infected children. Perinatal AIDS Collaborative Transmission Study.

R. Steketee, D. Thea, L. Kuhn, 1999, The Journal of infectious diseases.

A 12‐month study of the effects of oral zidovudine on neurodevelopmental functioning in a cohort of vertically HIV‐infected inner‐city children

Chee-Jen Chang, S. Arpadi, Mara J. Hoberman, 1994, AIDS.

The effect of maternal viral load on the risk of perinatal transmission of HIV‐1

M. Kalish, R. Steketee, D. Thea, 1997, AIDS.

Aging cohort of perinatally human immunodeficiency virus-infected children in New York City. New York City Pediatric Surveillance of Disease Consortium.

K. Bornschlegel, J. Weedon, P. Thomas, 2001, The Pediatric infectious disease journal.

Neutralizing antibody and perinatal transmission of human immunodeficiency virus type 1. New York City Perinatal HIV Transmission Collaborative Study Group.

D. Thea, E. Abrams, R. Hengel, 1998, AIDS research and human retroviruses.

Timing of maternal‐infant HIV transmission: associations between intrapartum factors and early polymerase chain reaction results

R. Steketee, D. Thea, L. Kuhn, 1997, AIDS.

Effect of maternal CD4+ cell count, acquired immunodeficiency syndrome, and viral load on disease progression in infants with perinatally acquired human immunodeficiency virus type 1 infection. New York City Perinatal HIV Transmission Collaborative Study Group.

M. Kalish, D. Thea, T. Brown, 1997, The Journal of pediatrics.

Virologic, immunologic, and clinical evaluation of human immunodeficiency virus antibody status of symptom-free children born to infected mothers.

N. Chelyapov, K. Liu, P. Brunell, 1994, The Journal of pediatrics.

Pediatric HIV infection.

S. Pavlakis, A. Wiznia, S. Pavlakis, 1996, The Medical clinics of North America.

Prospective study of human immunodeficiency virus 1-related disease among 512 infants born to infected women in New York City. The New York City Perinatal HIV Transmission Collaborative Study Group.

D. Thea, J. Weedon, P. Thomas, 1996, The Pediatric infectious disease journal.

Aerosolized pentamidine for prophylaxis of Pneumocystis carinii pneumonia in infants with human immunodeficiency virus infection

I. Hand, A. Wiznia, G. Lambert, 1994, The Pediatric infectious disease journal.

A BRIEF ORIGINAL CONTRIBUTION

N. Shaffer, J. Weedon, P. Thomas, 1995 .

Testicular abscess due to Streptococcus pneumoniae in an infant with human immunodeficiency virus infection.

D. Beenhouwer, J. Dobroszycki, A. Wiznia, 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Benefit of primary prophylaxis before 18 months of age in reducing the incidence of Pneumocystis carinii pneumonia and early death in a cohort of 112 human immunodeficiency virus-infected infants. New York City Perinatal HIV Transmission Collaborative Study Group.

M. Bamji, G. Lambert, P. Matheson, 1996, Pediatrics.